Clinical Trial

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers

Name: Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers — clinical trial record (NCT07304726)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetics and safety of CKD-383 in healthy volunteers

Trial Details

NCT Number	NCT07304726
Lead Sponsor	Chong Kun Dang Pharmaceutical
Conditions	Type 2 Diabetes
Enrollment	30 participants
Start Date	2025-10-30
Primary Completion	2025-11-09 (estimated)
Study Completion	2025-11-23 (estimated)
Updated on ClinicalTrials.gov	2025-12-26